Prolongation of Kidney Graft Survival by Cyclophosphamide-induced Tolerance in Rats

Masatoshi Eto, Yousuke Nishimura, Kenichi Matsuo, Kazuya Omoto, Ken Goto, Joichi Kumuzawa, Kikuo Nomoto

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

In this study, we have extended a cyclophosphamide (CP)-induced tolerance system to kidney transplantation in rats to examine whether or not we can overcome fully allogeneic (major histocompatibility complex plus minor histocompatibility) antigen barriers in organ transplantation. In the recipient Lewis (LEW, RT11) rats that were primed intravenously with 4 X 108 spleen cells plus 2 X 108 bone marrow cells from Brown-Norway (BN, RT1n) rats and treated intraperitoneally with 100 mg./kg. of cyclophosphamide (CP) 2 days later, the survival of kidney allografts, but not skin allografts, from BN was prolonged as compared with that in the untreated LEW rats. Some of the kidney allografts survived for more than 100 days without further immunosuppressants. The tolerant state induced was tolerogen specific, and the suppression of tissue damage of the grafted kidney in such tolerant rats was also confirmed by the histopathological findings of the grafted kidney. These results indicate that considerable levels of tolerance can be induced, at least in organ transplantation, across fully allogeneic antigen barriers in rats by a CP-induced tolerance system. We believe that the present study is the first step in applying our CP-induced tolerance system using skin grafting in the murine model to clinical organ transplantation.

Original languageEnglish
Pages (from-to)1693-1696
Number of pages4
JournalThe Journal of Urology
Volume153
Issue number5
DOIs
Publication statusPublished - Jan 1 1995

Fingerprint

Graft Survival
Cyclophosphamide
Kidney
Organ Transplantation
Allografts
Inbred BN Rats
Minor Histocompatibility Antigens
Skin Transplantation
Norway
Immunosuppressive Agents
Major Histocompatibility Complex
Bone Marrow Cells
Kidney Transplantation
Spleen
Antigens
Skin

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Eto, M., Nishimura, Y., Matsuo, K., Omoto, K., Goto, K., Kumuzawa, J., & Nomoto, K. (1995). Prolongation of Kidney Graft Survival by Cyclophosphamide-induced Tolerance in Rats. The Journal of Urology, 153(5), 1693-1696. https://doi.org/10.1016/S0022-5347(01)67506-2

Prolongation of Kidney Graft Survival by Cyclophosphamide-induced Tolerance in Rats. / Eto, Masatoshi; Nishimura, Yousuke; Matsuo, Kenichi; Omoto, Kazuya; Goto, Ken; Kumuzawa, Joichi; Nomoto, Kikuo.

In: The Journal of Urology, Vol. 153, No. 5, 01.01.1995, p. 1693-1696.

Research output: Contribution to journalArticle

Eto, M, Nishimura, Y, Matsuo, K, Omoto, K, Goto, K, Kumuzawa, J & Nomoto, K 1995, 'Prolongation of Kidney Graft Survival by Cyclophosphamide-induced Tolerance in Rats', The Journal of Urology, vol. 153, no. 5, pp. 1693-1696. https://doi.org/10.1016/S0022-5347(01)67506-2
Eto, Masatoshi ; Nishimura, Yousuke ; Matsuo, Kenichi ; Omoto, Kazuya ; Goto, Ken ; Kumuzawa, Joichi ; Nomoto, Kikuo. / Prolongation of Kidney Graft Survival by Cyclophosphamide-induced Tolerance in Rats. In: The Journal of Urology. 1995 ; Vol. 153, No. 5. pp. 1693-1696.
@article{54abb20062da4c608113d8f8eee1d3db,
title = "Prolongation of Kidney Graft Survival by Cyclophosphamide-induced Tolerance in Rats",
abstract = "In this study, we have extended a cyclophosphamide (CP)-induced tolerance system to kidney transplantation in rats to examine whether or not we can overcome fully allogeneic (major histocompatibility complex plus minor histocompatibility) antigen barriers in organ transplantation. In the recipient Lewis (LEW, RT11) rats that were primed intravenously with 4 X 108 spleen cells plus 2 X 108 bone marrow cells from Brown-Norway (BN, RT1n) rats and treated intraperitoneally with 100 mg./kg. of cyclophosphamide (CP) 2 days later, the survival of kidney allografts, but not skin allografts, from BN was prolonged as compared with that in the untreated LEW rats. Some of the kidney allografts survived for more than 100 days without further immunosuppressants. The tolerant state induced was tolerogen specific, and the suppression of tissue damage of the grafted kidney in such tolerant rats was also confirmed by the histopathological findings of the grafted kidney. These results indicate that considerable levels of tolerance can be induced, at least in organ transplantation, across fully allogeneic antigen barriers in rats by a CP-induced tolerance system. We believe that the present study is the first step in applying our CP-induced tolerance system using skin grafting in the murine model to clinical organ transplantation.",
author = "Masatoshi Eto and Yousuke Nishimura and Kenichi Matsuo and Kazuya Omoto and Ken Goto and Joichi Kumuzawa and Kikuo Nomoto",
year = "1995",
month = "1",
day = "1",
doi = "10.1016/S0022-5347(01)67506-2",
language = "English",
volume = "153",
pages = "1693--1696",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Prolongation of Kidney Graft Survival by Cyclophosphamide-induced Tolerance in Rats

AU - Eto, Masatoshi

AU - Nishimura, Yousuke

AU - Matsuo, Kenichi

AU - Omoto, Kazuya

AU - Goto, Ken

AU - Kumuzawa, Joichi

AU - Nomoto, Kikuo

PY - 1995/1/1

Y1 - 1995/1/1

N2 - In this study, we have extended a cyclophosphamide (CP)-induced tolerance system to kidney transplantation in rats to examine whether or not we can overcome fully allogeneic (major histocompatibility complex plus minor histocompatibility) antigen barriers in organ transplantation. In the recipient Lewis (LEW, RT11) rats that were primed intravenously with 4 X 108 spleen cells plus 2 X 108 bone marrow cells from Brown-Norway (BN, RT1n) rats and treated intraperitoneally with 100 mg./kg. of cyclophosphamide (CP) 2 days later, the survival of kidney allografts, but not skin allografts, from BN was prolonged as compared with that in the untreated LEW rats. Some of the kidney allografts survived for more than 100 days without further immunosuppressants. The tolerant state induced was tolerogen specific, and the suppression of tissue damage of the grafted kidney in such tolerant rats was also confirmed by the histopathological findings of the grafted kidney. These results indicate that considerable levels of tolerance can be induced, at least in organ transplantation, across fully allogeneic antigen barriers in rats by a CP-induced tolerance system. We believe that the present study is the first step in applying our CP-induced tolerance system using skin grafting in the murine model to clinical organ transplantation.

AB - In this study, we have extended a cyclophosphamide (CP)-induced tolerance system to kidney transplantation in rats to examine whether or not we can overcome fully allogeneic (major histocompatibility complex plus minor histocompatibility) antigen barriers in organ transplantation. In the recipient Lewis (LEW, RT11) rats that were primed intravenously with 4 X 108 spleen cells plus 2 X 108 bone marrow cells from Brown-Norway (BN, RT1n) rats and treated intraperitoneally with 100 mg./kg. of cyclophosphamide (CP) 2 days later, the survival of kidney allografts, but not skin allografts, from BN was prolonged as compared with that in the untreated LEW rats. Some of the kidney allografts survived for more than 100 days without further immunosuppressants. The tolerant state induced was tolerogen specific, and the suppression of tissue damage of the grafted kidney in such tolerant rats was also confirmed by the histopathological findings of the grafted kidney. These results indicate that considerable levels of tolerance can be induced, at least in organ transplantation, across fully allogeneic antigen barriers in rats by a CP-induced tolerance system. We believe that the present study is the first step in applying our CP-induced tolerance system using skin grafting in the murine model to clinical organ transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0028924473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028924473&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)67506-2

DO - 10.1016/S0022-5347(01)67506-2

M3 - Article

C2 - 7715012

AN - SCOPUS:0028924473

VL - 153

SP - 1693

EP - 1696

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 5

ER -